Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Cancer Research - United States
doi 10.1158/0008-5472.can-18-2812
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2019
Authors
Publisher
American Association for Cancer Research (AACR)